Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
hDP-MSCs for Chronic Periodontitis
NCT05924373Phase 2Recruiting
- Sponsor
- Peking University Third Hospital
- Start
- Nov 2023
- Primary completion
- Mar 2025
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of human dental pulp mesenchymal stem cells in chronic periodontitis (4 arms), sponsored by Peking University Third Hospital. Primary endpoint: Changes from baseline in height of the periodontal bone defect at 180 days. Started Nov 2023; status: recruiting.
02
Drugs
human dental pulp mesenchymal stem cells
03
Conditions
chronic periodontitis
Beyond the preview
Go deeper on NCT05924373.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05924373.